Skip to content

Using GLP-1s

Shot day routines: how the GLP-1 community builds a weekly injection ritual

Once-weekly dosing turns "shot day" into a small ritual. People build routines around it: picking the right day, warming the pen to reduce sting, rotating sites, eating lighter, logging everything, and heading off side effects before they start. This is a tour of the common routines GLP-1 users swear by, and the reasons behind the ones worth copying.

By the glp1.how editorial teamReviewed 7 min read

Evidence-backed

Most GLP-1 medications are injected once a week, so "shot day" becomes a fixed point on the calendar, and a lot of people turn it into a small ritual. A repeatable routine makes the shot easier to remember, more comfortable to take, and less disruptive to the days around it. (GLP-1 pills now exist too, and they have a different routine. See comparing the GLP-1 pills. Everything below is about weekly injections.)

None of this is required for the medication to work. Still, the community has settled on a set of habits that help, and some are more practical than others. This is a tour of them.

One note on devices. Not everyone injects from a pen with a built-in needle. According to the 2026 labels, Wegovy comes in single-dose pens and syringes and a multi-dose FlexTouch pen, and Zepbound comes in single-dose pens and vials, multi-dose vials, and KwikPens. A vial or multi-dose pen adds steps such as drawing up or dialing a dose and keeping count, so check your own device's instructions and see pen types and injection technique.

Pick your day, and be a little strategic about it

The most common advice is simple: choose a day and stick to it. The Wegovy label says to inject on the same day each week, and the Zepbound label allows a change of day only if at least 3 days separate the two doses. A fixed day also turns the shot into a habit instead of a decision you revisit every week.

People get strategic about which day. Many notice side effects (nausea, fatigue, low appetite) most in the day or two after a dose. That fits with how the drugs are absorbed: the labels say semaglutide reaches its peak level in the blood 1 to 3 days after an injection, and tirzepatide at a median of 24 hours (range 8 to 72 hours). So many people pick a day where the following 24–48 hours are low-stakes. A common pattern is dosing on a Friday or Saturday so any queasiness lands on a quiet weekend instead of a big work day. Others do the opposite and dose early in the week, so appetite suppression is strongest when their eating is hardest to control. There's no single right answer. Match shot day to your week. (Our guide on what to realistically expect on a GLP-1 covers the side-effect timing this is built around.)

The shot days worth the most planning are the ones right after a dose increase. The 2024 multisociety perioperative guidance says the escalation phase carries a higher risk of delayed stomach emptying than the maintenance phase (Kindel et al., Clinical Gastroenterology and Hepatology, 2024, DOI (external link)), which is also when many people have their worst nausea. See gastric emptying on a GLP-1 for what that slowing is and how long it lasts.

Comfort tricks for the injection itself

Several routines are about making the shot sting less.

Let the pen warm up. Many people take the pen out 15–30 minutes ahead so it reaches room temperature, and manufacturers allow the pen to sit at room temperature before injecting (see our storage and travel guide for each brand's limits). The evidence for less sting is thinner than the folk wisdom suggests. One small trial of subcutaneous lidocaine injections found that warmed injections hurt less than room-temperature ones, but cold and room-temperature injections didn't differ significantly, and it wasn't a GLP-1 pen study (Lundbom et al., 2016, DOI (external link)). We found no GLP-1 pen study on injection temperature and pain. It's harmless to try; just don't expect a big difference.

Rotate injection sites. The labels list the abdomen (a couple of inches from the navel), the thigh, and the upper arm, and both the Wegovy and Zepbound labels say to rotate sites with each dose. The Zepbound label adds that another person should give the shot in the back of the upper arm, which is hard to reach on your own. It also reports similar tirzepatide exposure whether you inject in the abdomen, thigh, or upper arm, so the choice is mostly about comfort and rotation, not how well the drug is absorbed. Moving to a new spot each week helps avoid soreness and lumps (see injection-site reactions). International expert recommendations, written for diabetes injections, say not to inject into lumpy areas of thickened fatty tissue (lipohypertrophy) and that correct rotation helps prevent them (Frid et al., Mayo Clinic Proceedings, 2016, DOI (external link)). That guidance isn't GLP-1-specific, but the same injection principles apply. A lot of people keep a simple rotation log so they remember where the last one went.

Numb or distract. Some people ice the spot for a moment first; others pinch the skin, exhale on the click, or look away. These are small things, and none has been tested for GLP-1 pens, but they take the edge off shot anxiety.

Tie it to something you already do. The Wegovy and Zepbound labels let you inject at any time of day, so the exact hour matters less than remembering. Pairing the shot with something you already do weekly, like Sunday coffee or a Friday wind-down, makes it easier to remember.

If the needle itself fills you with dread, you're not alone. Building a calm, predictable routine is a common approach.

If you miss your shot day

It happens, and the rule depends on the drug. The Zepbound label says to take a missed dose as soon as possible within 4 days (96 hours); after more than 4 days, skip it and take the next dose on your regular day. The Wegovy label says to take a missed dose as soon as possible if the next scheduled dose is more than 2 days away. Rules for other drugs differ, so check yours. Our guide on what to do if you miss a GLP-1 dose covers the rules by drug, and if you've missed more than one dose, see restarting after a gap, since going straight back to your old dose can be risky. Don't double up to catch up (see what happens if you accidentally take a double dose).

Eating around the shot

Appetite and nausea shift after a dose, so food routines cluster on shot day and the day after. Many people go lighter and blander on both days: smaller portions and less greasy or fried food, which tends to sit worst when nausea is up. (The side-effect guide has the specifics.) They also get protein and water in early while appetite is still cooperating, since intake often drops for a day or two. Our guides on protein and macros and hydration explain why this matters more than it seems. And they keep easy backups on hand, such as broth, yogurt, crackers, and electrolyte drinks, so a low-appetite day doesn't become a no-nutrition day.

Track it

Shot day is a natural checkpoint, and logging is one of the most common routines. The basics are the dose and the date, especially during titration when the dose changes, plus the injection site so rotation actually happens. Many people also record weight, measurements, or photos on the same day each week for a consistent comparison, and a quick note on symptoms and appetite. That note makes patterns visible and gives your prescriber real information.

Some people use dedicated apps, some a notes file, some a paper journal. The tool matters far less than doing it on the same day each week.

"Pre-gaming": heading off side effects before they start

Some people call this part pre-gaming: prepping your body and your schedule on the day before and the day of the shot so side effects have less to work with. Experienced users often treat shot day as prevention day. They have anti-nausea strategies ready before symptoms hit: ginger, small frequent snacks, staying upright after eating, and any anti-nausea medication their prescriber has offered. They get hydration and protein in early, ahead of the appetite drop, instead of trying to catch up once they don't feel like eating. They plan around fatigue by not scheduling the most demanding tasks for the 24 hours after the dose if they can help it. And they stay ahead of constipation, a slower-building side effect, with fiber and fluids through the week (see constipation on a GLP-1).

The idea is that side effects are easier to prevent than to chase. A little prep on shot day beats scrambling for remedies the morning after. To be clear about the evidence: "pre-gaming" is a community term, and most of these tactics haven't been tested as shot-day strategies. Keep the ones that help you, and talk to your prescriber about medication for nausea.

The ritual and the mental side

Beyond the logistics, a lot of people describe shot day as a weekly moment of intention: a check-in with their goals, a small reward afterward, or a standing time to post in a community thread and compare notes. Many find that sharing shot-day updates keeps them accountable and makes the routine feel less clinical and lonely. (glp1.how is the information; glp1.community is where a lot of that day-to-day peer support happens.)

Make it yours

The best shot-day routine is the one you'll actually repeat. Borrow what's useful here and drop the rest. The medical essentials are few: consistent timing, site rotation, safe sharps disposal, and telling your care team how it's going. Everything else is comfort and habit, and those are yours to design.

Study findings above are attributed to their authors and were located via PubMed.

This is general education and shared community practice, not medical advice. Follow your medication's instructions and your prescriber's guidance on how and when to inject.

shot-dayinjectiondosingroutinecommunityside-effectshabitstreatment

Common questions

Questions people often ask about this topic.

  • What does "pre-gaming" mean in the GLP-1 community?

    It's a community term for prepping your body and schedule on the day before and the day of your shot so side effects have less to work with: getting hydration and protein in early before appetite drops, having anti-nausea remedies ready before symptoms start, planning lighter meals, and not scheduling demanding tasks for the day after. The idea is that side effects are easier to prevent than to chase. Most of these tactics haven't been tested as shot-day strategies.

  • What day of the week is best for a GLP-1 shot?

    There's no medically "best" day; consistency matters more than which day. Many people pick a day so that the following 24–48 hours, when side effects tend to be most noticeable, fall on a low-stakes stretch, like dosing Friday or Saturday for a quiet weekend. Others dose early in the week to blunt appetite when eating is hardest. Match it to your own schedule and keep it the same each week. The Zepbound label allows a change of day only if at least 3 days separate the two doses.

  • What if I miss my shot day?

    The rule depends on the drug. The Zepbound label says to take a missed dose as soon as possible within 4 days (96 hours), and to skip it if more than 4 days have passed. The Wegovy label says to take it as soon as possible if the next scheduled dose is more than 2 days away. Check your own drug's label, don't double up to catch up, and if you've missed more than one dose, ask your prescriber whether to restart at a lower dose.

  • How do I make the injection sting less?

    The most common fixes: take the pen out of the fridge 15–30 minutes ahead so it reaches room temperature (manufacturers allow this, though the evidence that it reduces sting is thin; one small trial found cold and room-temperature injections didn't differ significantly, and no GLP-1 pen study was found); rotate sites each week; and numb or distract with a moment of ice, a skin pinch, or looking away. A calm, predictable routine is a common way to handle needle anxiety.

  • Where should I inject, and why rotate sites?

    The labels list the abdomen (a couple of inches from the navel), the thigh, and the upper arm. The Zepbound label says another person should inject in the back of the upper arm, and reports similar tirzepatide exposure across the three sites. Rotating each week instead of using the same spot helps prevent soreness and lumps, and expert injection guidance says not to inject into lumpy, thickened areas. Many people keep a simple log of where the last shot went. Always follow your medication's specific instructions.

  • What should I eat on shot day?

    A common routine is to go lighter and blander on shot day and the day after, with smaller portions and less greasy or fried food, since nausea tends to rise after a dose. Get protein and water in early while your appetite is still cooperating, and keep easy backups like broth, yogurt, and electrolyte drinks on hand so a low-appetite day doesn't become a no-nutrition day. Shot days right after a dose increase are the ones most worth planning for.

  • Do I need to track anything on shot day?

    It's not required, but shot day is a natural weekly checkpoint and most people log something: the dose and date (especially during titration), the injection site for rotation, weight or photos on the same day for consistency, and a quick note on symptoms and appetite. That last one gives your prescriber real information to work with. An app, a notes file, or paper all work.

Evidence

The sources behind this article, labeled by type and strength.

Supporting4

  • New injection recommendations for patients with diabetes (external link)

    Diabetes & Metabolism (Frid et al., 2010) — via PubMed · Clinical guideline · Moderate evidence

    Frid A, Hirsch L, Gaspar R, et al. (2010) · Diabetes Metab

    doi:10.1016/S1262-3636(10)70002-1

    Evidence-based, expert-vetted injection guidelines covering the core practices in this article — site rotation to avoid lipohypertrophy, injection technique, storage, safe sharps disposal, and GLP-1 analogs specifically. Grounds the 'medical essentials' of shot day. Consensus recommendations (moderate).

  • New Insulin Delivery Recommendations (external link)

    Mayo Clinic Proceedings (Frid et al., 2016) — via PubMed · Clinical guideline · Moderate evidence

    Frid AH, Kreugel G, Grassi G, et al. (2016) · Mayo Clin Proc

    doi:10.1016/j.mayocp.2016.06.010

    Newer FITTER expert recommendations (183 experts, 54 countries) for diabetes injections: do not inject into lipohypertrophy lesions, correct site rotation helps prevent them, shortest needles first-line, avoid intramuscular injection, dispose of sharps safely. Written for insulin and diabetes injections, so applying it to GLP-1 pens is an extrapolation; needle-length advice applies mainly to pens with attached needles.

  • WEGOVY (semaglutide) injection prescribing information (external link)

    FDA label via DailyMed, rev. June 2026 · Clinical guideline · Strong evidence

    (2026)

    'Maximum concentration of semaglutide is reached 1 to 3 days post dose' (same wording in the Ozempic label). Supports the timing behind picking a low-stakes day after the shot; the label gives drug levels, not symptom timing. Section 2.1 (read September 2026): administer once weekly 'on the same day each week, at any time of day, with or without meals'. Re-read September 2026: inject 'subcutaneously in the abdomen, thigh, or upper arm... Rotate injection sites with each dose'; missed dose: if the next scheduled dose is more than 2 days away, administer as soon as possible (the rest of the rule was not retrieved, so the article links the missed-dose guide); presentations include single-dose pens (including 7.2 mg Wegovy HD), single-dose syringes and the multi-dose FlexTouch pen.

  • ZEPBOUND (tirzepatide) prescribing information (external link)

    FDA label via DailyMed, rev. August 2026 · Clinical guideline · Strong evidence

    (2026)

    'The median time (range) to maximum plasma concentration of tirzepatide is 24 hours (8 to 72 hours).' Same caveat: drug levels, not symptom timing. Verified wording (read September 2026): 'The day of weekly administration can be changed, if necessary, as long as the time between the two doses is at least 3 days (72 hours)'; missed dose: administer 'as soon as possible within 4 days (96 hours)', and if more than 4 days have passed, skip it; inject 'in the abdomen, thigh, or another person should inject in the back of the upper arm. Rotate injection sites with each dose'; 'Similar exposure was achieved with subcutaneous administration of tirzepatide in the abdomen, thigh, or upper arm'; presentations include single-dose pens and vials, multi-dose vials and KwikPens.

Mixed findings2

Revision history

Updated 8 times since Sep 2, 2026 · show changes
  1. v9

    Common questions 6 → 7

  2. v8

    Evidence sources 4 → 6

  3. v7

    Body revised

  4. v6

    Evidence sources revised

  5. v5

    Body revised

  6. v4

    Evidence sources 2 → 4

  7. v3

    Common questions revised

  8. v2

    Summary rewritten; Body revised

  9. v1

    Change tracking began

Related guides

  • Safe sharps disposal for GLP-1 injectors · Every GLP-1 injection ends with a needle you have to put somewhere. This guide walks through the FDA's two-step system: a proper sharps container (or an acceptable heavy-duty household stand-in), the short list of things never to do with a used needle, how to find your community's disposal rules, and what changes when you travel.
  • Liraglutide (Victoza and Saxenda): how the daily GLP-1 differs · Liraglutide (Victoza for diabetes, Saxenda for weight) was the first GLP-1 approved for weight management. It's a daily injection with a half-life of about 13 hours and generally more modest weight loss than the weekly drugs. What makes it different, and why some people still choose it.
  • GLP-1 microdosing: what it means, why people do it, and what the evidence actually says · "Microdosing" GLP-1s is all over social media: using much smaller doses than the label calls for, for weight maintenance, side-effect avoidance, cost, or vague wellness claims. What the term means, the real medicine it borrows from, why no clinical trial has tested it, the specific risks of the DIY version, and how to have a lower-dose conversation with your prescriber instead.
  • When and why a prescriber might slow down your titration · You can stay at a dose step longer than the standard titration schedule says. This guide covers what the labels allow, the common reasons prescribers extend a step, and how to raise it.
  • Pen types and injection technique across GLP-1 brands · Not all GLP-1 pens work the same way. Some are pre-set single-dose auto-injectors; others need a needle attached, a dose set, and a priming step. A brand-by-brand comparison and the technique habits that apply to every pen.
  • Restarting a GLP-1 after a missed stretch: what each drug's label says about re-titration · Missed a few weeks of Wegovy, Zepbound, Ozempic, Trulicity, Saxenda, or a GLP-1 pill? Only four labels spell out when to restart at a lower dose: Wegovy injection after 2 missed weekly doses, Saxenda and Victoza after more than 3 days, and Foundayo after 7 missed daily doses. The rest are silent on long gaps. This by-drug reference separates what each label says from what's left to your prescriber, and explains why going straight back to your old dose is risky.

Related terms

  • GLP-1 · A gut hormone (glucagon-like peptide-1) that stimulates insulin release, slows digestion, and reduces appetite; the target of drugs like semaglutide and liraglutide.
  • Zepbound · Eli Lilly's brand name for injectable tirzepatide, FDA-approved for chronic weight management and for moderate-to-severe obstructive sleep apnea in adults with obesity.
  • Wegovy · Novo Nordisk's brand name for semaglutide (weekly injection or, since December 2025, a daily pill), FDA-approved for chronic weight management and heart-risk reduction, and as an injection for MASH liver disease.
  • Appetite suppression · A reduction in the drive or desire to eat, distinct from the fullness felt during or after a meal.
  • Tirzepatide · A once-weekly dual GIP and GLP-1 receptor agonist made by Eli Lilly, marketed as Mounjaro for type 2 diabetes and Zepbound for weight management and obstructive sleep apnea.
  • Semaglutide · A GLP-1 receptor agonist medication made by Novo Nordisk, sold under the brand names Ozempic (type 2 diabetes) and Wegovy (weight management), each as an injection or a pill.
  • Lipohypertrophy · A rubbery lump of thickened fatty tissue under the skin caused by repeated injections in the same spot.
  • Titration · The gradual, step-by-step increase of a medication dose over time, used to reduce side effects.

Was this helpful?

Improve this page